JP Morgan Chase
WVE icon

JP Morgan Chase’s Wave Life Sciences WVE Stock Holding History

JP Morgan Chase’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,800
Closed -$756K – 5986
2019
Q2 		$756K Buy
28,800
+11,800
+69% +$331K ﹤0.01% 4015
2019
Q1 		$660K Buy
+17,000
New +$690K ﹤0.01% 4048

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

JP Morgan Chase's WVE Position: Q2 2026 in Review

JP Morgan Chase reduced its Wave Life Sciences (WVE) stake by 7.8% in Q2 2026, selling an estimated $345K and leaving 618,172 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

JP Morgan Chase first reported a position in WVE in Q4 2016 and has held it in 38 quarters since. The position peaked at $15.2M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • JP Morgan Chase held 618,172 shares of Wave Life Sciences worth $3.55M as of Q2 2026.
  • JP Morgan Chase sold 51,998 Wave Life Sciences shares in Q2 2026, an estimated $345K.
  • Wave Life Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3746 holding.
  • JP Morgan Chase first reported a position in Wave Life Sciences in Q4 2016 and has held it in 38 quarters since.
  • JP Morgan Chase's Wave Life Sciences position peaked at $15.2M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.